• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
Free ACCA & CIMA online courses from OpenTuition

Free ACCA & CIMA online courses from OpenTuition

Free Notes, Lectures, Tests and Forums for ACCA and CIMA exams

  • ACCA
  • CIMA
  • FIA
  • OBU
  • Books
  • Forums
  • Ask AI
  • Search
  • Register
  • Login
  • ACCA Forums
  • Ask ACCA Tutor
  • CIMA Forums
  • Ask CIMA Tutor
  • FIA
  • OBU
  • Buy/Sell Books
  • All Forums
  • Latest Topics

June 2025 ACCA Exam Results

Comments & Instant poll >>

20% off ACCA & CIMA Books

OpenTuition recommends the new interactive BPP books for June 2025 exams.
Get your discount code >>

Compound instrument valuation and treatment !

Forums › Ask ACCA Tutor Forums › Ask the Tutor ACCA FR Exams › Compound instrument valuation and treatment !

  • This topic has 1 reply, 2 voices, and was last updated 10 years ago by MikeLittle.
Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • June 27, 2015 at 6:01 pm #258943
    daina5
    Member
    • Topics: 12
    • Replies: 9
    • ☆

    A company issues $20m of 4% convertible loan notes at par on 1 January 2009. The loan notes are redeemable for cash or convertible into equity shares on the basis of 20 shares per $100 of debt at the option of the loan note holder on 31 December 2011. Similar but non-convertible loan notes carry an interest rate of 9%. Required Show how these loan notes should be accounted for in the financial statements at 31 December 2009.
    Answer
    $ Statement of profit or loss
    Finance costs (W2) 1,568
    Statement of financial position
    Equity – option to convert (W1) 2,576
    Non-current liabilities
    4% convertible loan notes (W2) 18,192

    Workings
    1) Equity and liability elements $’000

    3 years interest (20,000 × 4% × 2.53) 2,024
    Redemption (20,000 × 0.77) 15,400
    Liability element 17,424
    Equity element (?) 2,576
    Proceeds of loan notes 20,000

    2) Loan note balance $’000
    Liability element (W1) 17,424
    Interest for the year at 9% + 1,568
    Less interest paid (20,000 × 4%) ( 800)
    Carrying value at 31 December 2009 = 18,192

    I am unable to grab the working 2 in which loan note balance has been calculated …Sir could you brief me upon the same ?

    June 27, 2015 at 9:13 pm #258954
    MikeLittle
    Keymaster
    • Topics: 27
    • Replies: 23327
    • ☆☆☆☆☆

    Prepare a schedule of cash flows relating to the loan notes:

    (800,000) December 2009
    (800,000) December 2010
    (20,800,000) December 2011

    Discounting those values at 9% for 1, 2 and 3 years respectively gives us:

    $ 733,945
    $ 673,344 and
    $16,061,415

    That adds up to $17,468,704 ( according to your quoted figures, that is $17,424,000 – the difference is their error due to rounding)

    If we have a note issued for $20,000,000 and the debt element is $17,468,704 then the equity element must be the difference of $2,531,296

    Is that better?

  • Author
    Posts
Viewing 2 posts - 1 through 2 (of 2 total)
  • You must be logged in to reply to this topic.
Log In

Primary Sidebar

Donate
If you have benefited from our materials, please donate

ACCA News:

ACCA My Exam Performance for non-variant

Applied Skills exams is available NOW

ACCA Options:  “Read the Mind of the Marker” articles

Subscribe to ACCA’s Student Accountant Direct

ACCA CBE 2025 Exams

How was your exam, and what was the exam result?

BT CBE exam was.. | MA CBE exam was..
FA CBE exam was.. | LW CBE exam was..

Donate

If you have benefited from OpenTuition please donate.

PQ Magazine

Latest Comments

  • Josfel on Relevant cash flows for DCF Taxation (example 4) – ACCA Financial Management (FM)
  • askar.turganbayev@gmail.com on AA Chapter 2 Questions
  • RashidMh on MA Chapter 1 Questions Accounting for Management
  • John Moffat on Relevant Cash Flows for DCF Relevant Costs (example 1) – ACCA Financial Management (FM)
  • John Moffat on Accounting for Management – ACCA Management Accounting (MA)

Copyright © 2025 · Support · Contact · Advertising · OpenLicense · About · Sitemap · Comments · Log in